Barclays’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.01M | Buy |
246,670
+63,939
| +35% | +$520K | ﹤0.01% | 2225 |
|
|
2025
Q1 | $1.44M | Buy |
182,731
+69,693
| +62% | +$547K | ﹤0.01% | 2257 |
|
|
2024
Q4 | $1.68M | Sell |
113,038
-5,655
| -5% | -$84.2K | ﹤0.01% | 2325 |
|
|
2024
Q3 | $1.82M | Buy |
118,693
+39,015
| +49% | +$597K | ﹤0.01% | 2248 |
|
|
2024
Q2 | $1.21M | Sell |
79,678
-108,193
| -58% | -$1.65M | ﹤0.01% | 2014 |
|
|
2024
Q1 | $3.55M | Sell |
187,871
-15,022
| -7% | -$284K | ﹤0.01% | 1547 |
|
|
2023
Q4 | $3.88M | Sell |
202,893
-267,883
| -57% | -$5.12M | ﹤0.01% | 1687 |
|
|
2023
Q3 | $8.45M | Buy |
470,776
+304,683
| +183% | +$5.47M | 0.01% | 922 |
|
|
2023
Q2 | $3.37M | Buy |
166,093
+3,642
| +2% | +$74K | ﹤0.01% | 1451 |
|
|
2023
Q1 | $2.96M | Buy |
162,451
+36,413
| +29% | +$664K | ﹤0.01% | 1399 |
|
|
2022
Q4 | $2.61M | Sell |
126,038
-42,672
| -25% | -$883K | ﹤0.01% | 1478 |
|
|
2022
Q3 | $4.41M | Buy |
168,710
+133,006
| +373% | +$3.48M | ﹤0.01% | 1165 |
|
|
2022
Q2 | $905K | Buy |
35,704
+5,128
| +17% | +$130K | ﹤0.01% | 2168 |
|
|
2022
Q1 | $965K | Sell |
30,576
-27,336
| -47% | -$863K | ﹤0.01% | 2345 |
|
|
2021
Q4 | $2.34M | Buy |
57,912
+2,102
| +4% | +$85.1K | ﹤0.01% | 1719 |
|
|
2021
Q3 | $1.95M | Buy |
55,810
+49,753
| +821% | +$1.74M | ﹤0.01% | 1899 |
|
|
2021
Q2 | $166K | Sell |
6,057
-66,514
| -92% | -$1.82M | ﹤0.01% | 2961 |
|
|
2021
Q1 | $2.04M | Buy |
72,571
+26,497
| +58% | +$744K | ﹤0.01% | 1839 |
|
|
2020
Q4 | $1.2M | Sell |
46,074
-11,911
| -21% | -$309K | ﹤0.01% | 1875 |
|
|
2020
Q3 | $995K | Buy |
57,985
+5,836
| +11% | +$100K | ﹤0.01% | 1927 |
|
|
2020
Q2 | $1.29M | Buy |
52,149
+37,235
| +250% | +$921K | ﹤0.01% | 1770 |
|
|
2020
Q1 | $207K | Sell |
14,914
-22,323
| -60% | -$310K | ﹤0.01% | 2525 |
|
|
2019
Q4 | $376K | Buy |
37,237
+15,024
| +68% | +$152K | ﹤0.01% | 2849 |
|
|
2019
Q3 | $203K | Sell |
22,213
-28,392
| -56% | -$259K | ﹤0.01% | 3052 |
|
|
2019
Q2 | $402K | Buy |
50,605
+40,134
| +383% | +$319K | ﹤0.01% | 2844 |
|
|
2019
Q1 | $131K | Buy |
10,471
+8,871
| +554% | +$111K | ﹤0.01% | 3215 |
|
|
2018
Q4 | $17K | Sell |
1,600
-4,026
| -72% | -$42.8K | ﹤0.01% | 3429 |
|
|
2018
Q3 | $78K | Buy |
5,626
+2,371
| +73% | +$32.9K | ﹤0.01% | 3554 |
|
|
2018
Q2 | $41K | Buy |
+3,255
| New | +$41K | ﹤0.01% | 3350 |
|